MerckProductServices - Singulair For Symptoms of Allergic Rhinitis

For US Healthcare Professionals


User name (Forgotten?) Password (Forgotten?) Remember me You can use your MerckMedicus^™ user name and password. Need to Register?

ASMANEX®
TWISTHALER®
(mometasone furoate inhalation powder) AVELOX®
(moxifloxacin hydrochloride)

(Please see Prescribing Information, including Boxed Warning, about increased risk of tendinitis and tendon rupture and exacerbation of muscle weakness in patients with myasthenia gravis.)

(See Medication Guide)

AVELOX® I.V.
(moxifloxacin hydrochloride in sodium chloride injection)

(Please see Prescribing Information, including Boxed Warning, about increased risk of tendinitis and tendon rupture and exacerbation of muscle weakness in patients with myasthenia gravis.)

(See Medication Guide)

CANCIDAS®
(caspofungin acetate) CLARINEX®
(desloratadine) CLARINEX-D®
12 HOUR
(desloratadine/
pseudoephedrine
sulfate) CLARINEX-D®
24 HOUR
(desloratadine/
pseudoephedrine
sulfate) DULERA®
(mometasone furoate/formoterol fumarate dihydrate) Inhalation Aerosol

(Please read the Boxed Warning about asthma-related death in the Prescribing Information.)

(See Medication Guide)

EMEND®
(aprepitant) EMEND®
(fosaprepitant dimeglumine) for Injection FOLLISTIM® AQ
(follitropin beta injection) INVANZ®
(ertapenem sodium) ISENTRESS®
(raltegravir) JANUMET®
(sitagliptin/metformin HCl) tablets

(Please read the Boxed Warning about lactic acidosis in the Prescribing Information.)

(See Medication Guide)

JANUVIA®
(sitagliptin) tablets MAXALT®
(rizatriptan benzoate) MAXALT-MLT®
(rizatriptan benzoate)Orally Disintegrating Tablets NASONEX®
(mometasone furoate monohydrate)
Nasal Spray, 50 mcg, calculated on the anhydrous basis NuvaRing®
(etonogestrel/ethinyl estradiol vaginal ring)

(Please read the Boxed Warning about serious cardiovascular events, especially in women who smoke, in the Prescribing Information.)

(See Patient Information)

PREGNYL®
(chorionic gonadotropin for injection, USP) PROPECIA®
(finasteride) PROVENTIL®
HFA
(albuterol sulfate) SINGULAIR®
(montelukast sodium) TEMODAR®
(temozolomide) TEMODAR®
(temozolomide) for Injection VICTRELIS™
(boceprevir) VYTORIN®
(ezetimibe/simvastatin) ZETIA®
(ezetimibe) ZOLINZA®
(vorinostat)

Contact Us

SINGULAIR^® (montelukast sodium)
For Symptoms of Allergic Rhinitis

Please see important product information below.

Educational Resources

No educational resources related to SINGULAIR^® (montelukast sodium) For Symptoms of Allergic Rhinitis are available at this time.

You can request a number of complimentary resources, where available, including:

Patient Educational Materials
Disease Management Tools
Journal Reprints
Slide Sets

View Educational Resources for all products

IMPORTANT PRODUCT INFORMATION

SINGULAIR is indicated for relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.

Neuropsychiatric events have been reported in patients taking SINGULAIR. These events included agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnambulism, suicidal thinking and behavior (including suicide), and tremor. The clinical details of some postmarketing reports appear consistent with a drug-induced effect. Patients should be advised to report any neuropsychiatric events.

The most common adverse reactions with an incidence >5% and greater than placebo in controlled clinical trials were upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, and otitis.

SINGULAIR is contraindicated in patients with hypersensitivity to any component of this product.

Before prescribing SINGULAIR, please read the Prescribing Information. The Patient Information also is available.

All product names listed on this site are registered trademarks owned by or licensed to a subsidiary of Merck & Co., Inc.
MerckProductServices, MerckServices, MerckSource, Merck OnCall, MerckMedicus, and MerckEngage are trademarks or registered trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.